+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allogeneic Stem Cells Market by Tissue Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells), Application (Cardiovascular, Immunotherapy, Neurological Disorders), Source, Product Type, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Allogeneic Stem Cells Market by Tissue Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells), Application (Cardiovascular, Immunotherapy, Neurological Disorders), Source, Product Type, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Allogeneic Stem Cells Market by Tissue Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells), Application (Cardiovascular, Immunotherapy, Neurological Disorders), Source, Product Type, End-User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015053
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allogeneic stem cells market is entering a new era characterized by rapid technological advancements, regulatory shifts, and transformative partnerships. Senior decision-makers face a dynamic environment where innovation, scalability, and resilience are critical factors for driving sustainable growth and unlocking new therapeutic opportunities.

Market Snapshot: Allogeneic Stem Cells Market Growth and Outlook

The Allogeneic Stem Cells Market grew from USD 328.34 million in 2024 to USD 393.14 million in 2025. It is expected to continue growing at a CAGR of 19.01%, reaching USD 933.17 million by 2030. This significant trajectory reflects an increasing adoption of off-the-shelf cell therapies across multiple therapeutic areas, enhanced by advances in manufacturing, biotechnology, and integration with contract manufacturing organizations. The market's expansion is propelled by both established and emerging stakeholders responding to unmet clinical needs and regulatory advancements.

Scope & Segmentation

This report offers a comprehensive analysis across critical segments and regions:

  • Tissue Types: Hematopoietic stem cells (from bone marrow and peripheral blood), Mesenchymal stem cells (from adipose tissue, bone marrow, and umbilical cord).
  • Applications: Cardiovascular (myocardial infarction, peripheral arterial disease), immunotherapy (CAR-T, dendritic cell, NK cell therapies), neurological disorders (including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis), orthopedics (bone regeneration, cartilage repair, spine fusion), wound healing (burns, chronic and diabetic ulcers).
  • Sources: Adipose tissue, bone marrow, peripheral blood, umbilical cord.
  • Product Forms: Cryopreserved, freeze dried, fresh cell products guaranteeing a range of deployment and storage options.
  • End-Users: Contract manufacturing organizations, hospitals and clinics, research institutes.
  • Distribution Pathways: Direct sales, distributor channels, online platforms.
  • Geographic Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering major countries across Western, Central, and Eastern Europe, the Gulf, and Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Leading Companies: Mesoblast Limited, Pluristem Therapeutics, Athersys, Gamida Cell, Cynata Therapeutics, Fate Therapeutics, Allogene Therapeutics, Celularity, TiGenix, Osiris Therapeutics.

Additionally, the report highlights novel technologies such as gene editing, automated bioreactor systems, and integrated quality control analytics shaping the future of scalable cell-based therapies.

Key Takeaways for Strategic Decision-Makers

  • Allogeneic stem cell products enable rapid treatment deployment by shifting from patient-specific to donor-sourced cell banking, addressing time and cost challenges in regenerative medicine.
  • Recent collaborations between biopharma and contract manufacturing organizations enhance both scalability and cost efficiency, supporting broader clinical adoption of innovative therapies.
  • Modular manufacturing solutions and automation are transforming supply chains, supporting flexible production scaling and reducing lead times for diverse therapeutic applications.
  • Advanced regulatory frameworks, including accelerated pathways, facilitate faster clinical trial progress for next-generation cell therapies, prompting increased investments and global commercialization.
  • Industry focus on robust safety profiles and reproducible manufacturing standards aims to align with payer requirements and clinical best practices, strengthening long-term market readiness.
  • Emerging markets in Asia-Pacific, Middle East & Africa, and Latin America are advancing infrastructure and regulatory standards, expanding access to allogeneic therapies and clinical studies.

Tariff Impact on the Allogeneic Stem Cells Market

Newly introduced United States tariffs on imported raw materials and consumables are increasing upstream costs and driving companies to strengthen supply chain resiliency. Strategic responses include diversifying supplier networks, investing in local manufacturing hubs, and reevaluating contractual terms between sponsors and manufacturing partners. These adaptations are fostering greater innovation in sourcing and formulation, even as they demand added regulatory coordination and capital investment.

Methodology & Data Sources

This analysis integrates in-depth interviews with executives and technical leaders in the cell therapy industry, bolstered by secondary research from peer-reviewed journals, regulatory filings, and government publications. All insights undergo triangulated data validation and review by industry panelists for accuracy and relevance.

Why This Report Matters

  • Gain clear, actionable insights into technology investments, clinical pipeline priorities, and competitive positioning across the allogeneic stem cells market ecosystem.
  • Identify evolving opportunities driven by new approval pathways, supply chain adjustments, and regional growth strategies.
  • Support confident, data-driven decisions for manufacturing expansion, regulatory engagement, and partnership development aligned with market transformation.

Conclusion

The allogeneic stem cells market offers senior leadership a clear path to scalable innovation and sustainable therapeutic impact. A flexible, evidence-driven strategy will be essential to capitalize on global growth opportunities and evolving regulatory frameworks across this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Strategic partnerships between academia and biopharma to accelerate allogeneic stem cell therapy pipelines
5.2. Advancements in gene editing of allogeneic stem cells for treatment of genetic blood disorders
5.3. Development of universal donor allogeneic stem cells through HLA knockout to minimize immune rejection
5.4. Adoption of automated closed process manufacturing systems to scale allogeneic cell therapy production
5.5. Integration of artificial intelligence in selection and quality control of allogeneic stem cell lines
5.6. Emergence of off-the-shelf CAR-T therapies derived from allogeneic stem cell platforms to reduce lead times
5.7. Regulatory harmonization and standardized potency assays to ensure consistency in allogeneic cell products
5.8. Expansion of cryopreservation and cold chain solutions to support global distribution of off-the-shelf cell therapies
5.9. Growing investment in allogeneic mesenchymal stem cell therapies targeting autoimmune and inflammatory diseases
5.10. Application of induced pluripotent stem cell derived allogeneic products in neurodegenerative disease indications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Allogeneic Stem Cells Market, by Tissue Type
8.1. Introduction
8.2. Hematopoietic Stem Cells
8.2.1. Bone Marrow
8.2.2. Peripheral Blood
8.3. Mesenchymal Stem Cells
8.3.1. Adipose Tissue
8.3.2. Bone Marrow
8.3.3. Umbilical Cord
9. Allogeneic Stem Cells Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Myocardial Infarction
9.2.2. Peripheral Arterial Disease
9.3. Immunotherapy
9.3.1. CAR-T Therapies
9.3.2. Dendritic Cell Therapies
9.3.3. NK Cell Therapies
9.4. Neurological Disorders
9.4.1. Alzheimers Disease
9.4.2. Multiple Sclerosis
9.4.3. Parkinsons Disease
9.4.4. Spinal Cord Injury
9.5. Orthopedics
9.5.1. Bone Regeneration
9.5.2. Cartilage Repair
9.5.3. Spine Fusion
9.6. Wound Healing
9.6.1. Burn Wounds
9.6.2. Chronic Wounds
9.6.3. Diabetic Foot Ulcers
10. Allogeneic Stem Cells Market, by Source
10.1. Introduction
10.2. Adipose Tissue
10.3. Bone Marrow
10.4. Peripheral Blood
10.5. Umbilical Cord
11. Allogeneic Stem Cells Market, by Product Type
11.1. Introduction
11.2. Cryopreserved
11.3. Freeze Dried
11.4. Fresh
12. Allogeneic Stem Cells Market, by End-User
12.1. Introduction
12.2. Contract Manufacturing Organizations
12.3. Hospitals and Clinics
12.4. Research Institutes
13. Allogeneic Stem Cells Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online Channels
14. Americas Allogeneic Stem Cells Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Allogeneic Stem Cells Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Allogeneic Stem Cells Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Mesoblast Limited
17.3.2. Pluristem Therapeutics, Inc.
17.3.3. Athersys, Inc.
17.3.4. Gamida Cell Ltd.
17.3.5. Cynata Therapeutics Limited
17.3.6. Fate Therapeutics, Inc.
17.3.7. Allogene Therapeutics, Inc.
17.3.8. Celularity, Inc.
17.3.9. TiGenix N.V.
17.3.10. Osiris Therapeutics, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ALLOGENEIC STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ALLOGENEIC STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ALLOGENEIC STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ALLOGENEIC STEM CELLS MARKET: RESEARCHAI
FIGURE 28. ALLOGENEIC STEM CELLS MARKET: RESEARCHSTATISTICS
FIGURE 29. ALLOGENEIC STEM CELLS MARKET: RESEARCHCONTACTS
FIGURE 30. ALLOGENEIC STEM CELLS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALLOGENEIC STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NK CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NK CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINE FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINE FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BURN WOUNDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BURN WOUNDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FREEZE DRIED, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FREEZE DRIED, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FRESH, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FRESH, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 174. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 175. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 176. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 177. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 180. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 181. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 182. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 183. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 184. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 185. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 186. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 187. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 188. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 189. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 190. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 191. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. CANADA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 207. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 208. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 209. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 214. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 215. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 221. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. MEXICO ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Allogeneic Stem Cells market report include:
  • Mesoblast Limited
  • Pluristem Therapeutics, Inc.
  • Athersys, Inc.
  • Gamida Cell Ltd.
  • Cynata Therapeutics Limited
  • Fate Therapeutics, Inc.
  • Allogene Therapeutics, Inc.
  • Celularity, Inc.
  • TiGenix N.V.
  • Osiris Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 393.14 Million
Forecasted Market Value ( USD ) by 2030 $ 933.17 Million
Compound Annual Growth Rate19.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Mesenchymal Stem Cells Market by Application (Autoimmune Disorders, Cardiovascular, Diabetes), Source (Adipose Tissue, Bone Marrow, Dental Pulp), End User, Product Type, Culture Method, Therapy Type - Global Forecast 2025-2030 - Product Image

Mesenchymal Stem Cells Market by Application (Autoimmune Disorders, Cardiovascular, Diabetes), Source (Adipose Tissue, Bone Marrow, Dental Pulp), End User, Product Type, Culture Method, Therapy Type - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2025 - Product Image

Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2025

  • Report
  • 381 Pages
  • Global
From
Mesenchymal Stem Cells Market Report 2025 - Product Image

Mesenchymal Stem Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From

About the Allogeneic Stem Cells Market

Allogeneic stem cells are stem cells derived from a donor, typically from a family member, and used to treat a variety of diseases and conditions. Allogeneic stem cells are used in a variety of medical treatments, including bone marrow transplants, cancer treatments, and regenerative medicine. Allogeneic stem cells are also used in research to study the effects of stem cells on diseases and conditions. The allogeneic stem cell market is a rapidly growing field, with a variety of companies offering products and services related to stem cell research and treatments. Companies in the allogeneic stem cell market include Celgene, Novartis, and Osiris Therapeutics, which offer products and services related to stem cell research and treatments. Other companies in the market include BioTime, Athersys, and Mesoblast, which offer products and services related to stem cell therapies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.